Psoralen photochemotherapy, clinical efficacy, and photomutagenicity: The role of molecular epidemiology in minimizing risks
Gasparro FP, Liao B, Foley PJ, Wang XM, McNiff J. Psoralen photochemotherapy, clinical efficacy, and photomutagenicity: The role of molecular epidemiology in minimizing risks. Environmental And Molecular Mutagenesis 1998, 31: 105-112. PMID: 9544188, DOI: 10.1002/(sici)1098-2280(1998)31:2<105::aid-em2>3.0.co;2-l.Peer-Reviewed Original ResearchMeSH KeywordsFicusinGenes, p53HumansMolecular EpidemiologyMutagenesisPhotosensitizing AgentsPoint MutationPUVA TherapyRisk AssessmentTreatment OutcomeConceptsSquamous cell carcinomaHuman squamous cell carcinomaP53 mutation spectrumMurine squamous cell carcinomaEfficacy of PUVATreatment of psoriasisP53 tumor suppressor geneMutation spectrumPsoriasis patientsUVB phototherapyClinical efficacyPsoralen photochemotherapyCell carcinomaTherapeutic historyPUVATumor progressionUVB exposureMolecular epidemiologyPatientsTumor suppressor geneHuman cancersCommon mutationsPsoriasisSkin cellsPhotochemotherapy